Strategic partnerships CRl has a history of global collaboration with academia, biotech, and industry partners and recent high-profile collaborations with SITC, 10x Genomics, Penn Medicine, Stanford, Memorial Sloan Kettering, and MSK. Target collaboration or sponsorship opportunities with leading research institutions, biotech firms, and CROs to co-create immunotherapy data platforms, joint grants, or sponsored research initiatives.

Open data initiative CRl launched an AI-driven immuno-oncology initiative and open immunotherapy research database in partnership with 10x Genomics and prominent medical centers. This indicates a strong need for data infrastructure, analytics tools, and cloud-based collaboration solutions. Sales opportunities exist in AI, data integration, privacy-compliant data sharing, and visualization platforms.

Grant and fellowship focus CRI actively funds researchers, supports young investigators, and accelerates high-risk ideas. There is potential to offer philanthropy-aligned software, grant management solutions, donor analytics, and impact reporting services to streamline grant administration and enhance fundraising outcomes.

Event and thought leadership CRI participates in major immunotherapy forums, awards, and conferences, including SITC events and annual galas. Sales opportunities include event tech (registration, sponsorship sales, attendee engagement platforms), digital marketing services, and data capture for donor and researcher engagement.

Scale and funding health With revenue estimated in the mid hundreds of millions and a relatively lean employee base, CRI represents an opportunity to offer scalable non-profit tech solutions, CRM optimization, financial systems integration, and dashboarding to improve grant tracking, impact measurement, and donor transparency as they grow.